Skip to content
OpenCapital
Get started

Edesa Biotech, Inc. EDSA Q4 2024 earnings

Reported February 14, 2025 · Before market open

Diluted EPS-$0.48Miss by $0.17
EPS estimate-$0.31

Next report

Aug 14, 2026 (in a month)
EPS estimate-$0.44

Versus estimates

Diluted EPS

Q1 2026-$0.49Miss by $0.25Q4 2025-$0.28In lineQ3 2025-$0.32Miss by $0.05Q2 2025-$0.25Beat by $0.01Q1 2025-$0.30In line
Q4 2024-$0.48Miss by $0.17

Ask the moment Edesa Biotech, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Edesa Biotech, Inc. report Q4 2024 earnings?
Edesa Biotech, Inc. (EDSA) reported Q4 2024 earnings on February 14, 2025 before market open.
What were Edesa Biotech, Inc.'s Q4 2024 revenue and EPS?
Edesa Biotech, Inc. reported diluted EPS of $-0.48 for Q4 2024.
Did Edesa Biotech, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.31 by $0.17.
Where can I find Edesa Biotech, Inc.'s Q4 2024 SEC filings?
You can read the 10-Q periodic report (0001171843-25-000866) directly on SEC EDGAR. The filing index links above go to sec.gov.